🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Gastric cancer is a high incidence in Asia, and one of the leading cause of...
Status
Completed
Location
Severance Hospital, Yonsei University Health System
Start Date
2016-12-12
Trial ID
NCT03814759
Treatments Being Tested
Since it is not uncertain about efficacy of combination therapy with PSK an...
Status
Unknown
Location
Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital
Start Date
2008-06
Trial ID
NCT00687843
Treatments Being Tested
The purpose of this study is to compare the efficacy between gemcitabine/ci...
Status
Terminated
Location
Gyeongsang University Hospital
Start Date
2010-07
Trial ID
NCT01096745
Treatments Being Tested
This study will evaluate the efficacy of docetaxel and S-1 combination chem...
Status
Unknown
Location
Hallym University Medical Center
Start Date
2011-11
Trial ID
NCT01693432
Treatments Being Tested
After curative resection, patients with stage IIIB-IV (M0) gastric cancer w...
Status
Terminated
Location
Kangbuk Samsung Hospital
Start Date
2015-05
Trial ID
NCT02191566
Treatments Being Tested
This is an open-label, randomized phase II study. Patients will be randomly...
Status
Completed
Location
Severance Hospital
Start Date
2008-10
Trial ID
NCT01269216
Treatments Being Tested
A single-arm phase II study to evaluate the efficacy and safety of docetaxe...
Status
Unknown
Location
Rongbo Lin
Start Date
2017-06-01
Trial ID
NCT03137004
Hypothesis: The addition of RAD001 to TS-1/CDDP is safe and can improved th...
Status
Terminated
Location
National University Hospital
Start Date
TBD
Trial ID
NCT01096199
Treatments Being Tested
This prospective, randomized phase II study is designed to evaluate weather...
Status
Completed
Location
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Start Date
2014-01
Trial ID
NCT02301481
This study will conduct a phase II study of gemcitabine, erlotinib, and S-1...
Status
Completed
Location
Hallym University Medical Center
Start Date
2011-08
Trial ID
NCT01693419
Treatments Being Tested